» Articles » PMID: 27038676

The Effect of Sex and Irritable Bowel Syndrome on HPA Axis Response and Peripheral Glucocorticoid Receptor Expression

Overview
Date 2016 Apr 4
PMID 27038676
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis has been reported in irritable bowel syndrome (IBS). Enhanced HPA axis response has been associated with reduced glucocorticoid receptor (GR) mediated negative feedback inhibition. We aimed to study the effects of IBS status, sex, or presence of early adverse life events (EAL) on the cortisol response to corticotropin-releasing factor (CRF) and adrenocorticotropic hormone (ACTH), and on GR mRNA expression in peripheral blood mononuclear cells (PBMCs).

Methods: Rome III+ IBS patients and healthy controls underwent CRF (1μg/kg ovine) and ACTH (250μg) stimulation tests with serial plasma ACTH and cortisol levels measured (n=116). GR mRNA levels were measured using quantitative PCR (n=143). Area under the curve (AUC) and linear mixed effects models were used to compare ACTH and cortisol response measured across time between groups.

Results: There were divergent effects of IBS on the cortisol response to ACTH by sex. In men, IBS was associated with an increased AUC (p=0.009), but in women AUC was blunted in IBS (p=0.006). Men also had reduced GR mRNA expression (p=0.007). Cumulative exposure to EALs was associated with an increased HPA response. Lower GR mRNA was associated with increased pituitary HPA response and increased severity of overall symptoms and abdominal pain in IBS.

Conclusion: This study highlights the importance of considering sex in studies of IBS and the stress response in general. Our findings also provide support for PBMC GR mRNA expression as a peripheral marker of central HPA response.

Citing Articles

Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism.

Camilleri M, Jencks K Expert Opin Drug Metab Toxicol. 2024; 20(5):319-332.

PMID: 38785066 PMC: 11139426. DOI: 10.1080/17425255.2024.2349716.


Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead.

Shin A, Kashyap P Gut Microbes. 2023; 15(1):2195792.

PMID: 37009874 PMC: 10072066. DOI: 10.1080/19490976.2023.2195792.


A review of neuroendocrine immune system abnormalities in IBS based on the brain-gut axis and research progress of acupuncture intervention.

Sun Z, Wang X, Feng S, Xie C, Xing Y, Guo L Front Neurosci. 2023; 17:934341.

PMID: 36968497 PMC: 10034060. DOI: 10.3389/fnins.2023.934341.


Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination.

Groeger D, Murphy E, Tan H, Larsen I, ONeill I, Quigley E Neurogastroenterol Motil. 2022; 35(1):e14477.

PMID: 36178333 PMC: 10078522. DOI: 10.1111/nmo.14477.


Adverse Childhood Experiences and Their Effect on Irritable Bowel Syndrome Among Saudi Arabian Adults.

Alsubaie M, Alkhalifah H, Ali A, Bahabri M, Alharbi B, Alfakeh S Cureus. 2022; 14(6):e25791.

PMID: 35812574 PMC: 9270910. DOI: 10.7759/cureus.25791.


References
1.
Ehlert U, Nater U, Bohmelt A . High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders. J Psychosom Res. 2005; 59(1):7-10. DOI: 10.1016/j.jpsychores.2005.03.005. View

2.
Walter S, Aardal-Eriksson E, Thorell L, Bodemar G, Hallbook O . Pre-experimental stress in patients with irritable bowel syndrome: high cortisol values already before symptom provocation with rectal distensions. Neurogastroenterol Motil. 2006; 18(12):1069-77. DOI: 10.1111/j.1365-2982.2006.00833.x. View

3.
Hepgul N, Cattaneo A, Zunszain P, Pariante C . Depression pathogenesis and treatment: what can we learn from blood mRNA expression?. BMC Med. 2013; 11:28. PMC: 3606439. DOI: 10.1186/1741-7015-11-28. View

4.
Webster M, Knable M, OGrady J, Orthmann J, Weickert C . Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry. 2002; 7(9):985-94, 924. DOI: 10.1038/sj.mp.4001139. View

5.
Chang L, Heitkemper M . Gender differences in irritable bowel syndrome. Gastroenterology. 2002; 123(5):1686-701. DOI: 10.1053/gast.2002.36603. View